Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes Annual Meeting 2026
Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market Facility
Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy 2026 Annual Meeting
Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Oreterra Geological Staff Mobilize to Trek South Copper-Gold Prospect, Golden Triangle, BC, to Prepare for Maiden Drill Program
